Samsung Biologics, AstraZeneca enter into global supply partnership
Samsung Biologics will offer large-scale commercial manufacturing in its Plant 3 along with drug product to support AstraZeneca's…
Sanofi, GSK to supply 300 million doses of Covid-19 vaccine to EU
21 Sep 20The potential Covid-19 vaccine candidate leverages Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant technology
RDIF, Dr. Reddy’s collaborate on Sputnik V vaccine trials and supply to India
17 Sep 20RDIF will supply Dr. Reddy's with 100 million doses of potential Covid-19 vaccine Sputnik V, upon receiving the…
Jardiance granted FDA Fast Track designation for improved cardiac outcomes
16 Sep 20The FDA designation enables development of Jardiance to prevent hospitalisation for heart failure and minimise the risk of…
Pfizer, BioNTech to begin Phase 2/3 trial of BNT162b2 in Germany
08 Sep 20The clinical trial in Germany will evaluate the safety and efficacy of potential Covid-19 vaccine candidate BNT162b2 in…
Gilead inks license deal with Jounce for cancer drug programme
02 Sep 20JTX-1811 is a monoclonal antibody, designed to selectively target immunosuppressive tumor-infiltrating T regulatory (TITR) cells
Engitix, Takeda collaborate to develop therapies for fibrotic liver diseases
26 Aug 20As part of the agreement, Takeda and Engitix will complete validation and preclinical development of new therapeutics for…
Sinovac, Bio Farma Indonesia collaborate on potential Covid-19 vaccine
26 Aug 20Sinovac will provide Bio Farma with bulk vaccine, enabling it manufacture a minimum of 40 million doses of…
Lilly expands Tyvyt licensing deal with Innovent Biologics
19 Aug 20Both Lilly and Innovent have been studying Tyvyt to treat non-squamous non-small cell lung cancer (NSCLC) and various…
AstraZeneca agrees with EC to supply 400 million doses of Covid-19 vaccine
17 Aug 20The current supply agreement follows AstraZeneca’s previous agreement with Inclusive Vaccines Alliance (IVA) to supply 400 million doses…